The Metoclopramide Injection, cataloged under National Stock Number 6505-01-268-3738, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-268-3738 |
| Primary Part Number | NDC00703-4502-04 |
| Item Name | Metoclopramide Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Supplementary Features | NOTE: F |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Protective Storage Feature | SUBJECT TO DAMAGE BY FREEZING |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00703-4502-04 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00409-3414-11 PRIMARY | Hospira Worldwide Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC00409-3414-01 | 5/9 Secondary reference Hospira, Inc. |
NSN 6505-01-268-3738 is a Metoclopramide Injection, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-268-3738 has 2 manufacturer part numbers on file: NDC00703-4502-04 (Teva Pharmaceuticals Usa, Inc.), NDC00409-3414-11 (Hospira Worldwide Llc).
Key specifications for NDC00703-4502-04: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 2.000 MILLILITERS; Supplementary Features: NOTE: F; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 8 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.